scholarly journals TYPE 2 DIABETIC PATIENTS

2016 ◽  
Vol 23 (06) ◽  
pp. 646-654
Author(s):  
Muhammad Umar Khan ◽  
Muhammad Tanveer Alam ◽  
Darshan Kumar ◽  
Muhammad Adnan ◽  
Muhammad Adnan ◽  
...  

Objectives: To determine the frequency of different types of self-reported sexualdysfunction among male type 2 diabetic patients attending diabetic clinics of National Instituteof Diabetes & Endocrinology (NIDE) at Karachi, Pakistan. Study Design: Descriptive crosssectional.Place and Duration of Study: National Institute of Diabetes & Endocrinology at DowUniversity Hospital, Ojha Campus, Karachi. From August 2014 to January 2015. Methodology:This study was conducted at diabetic clinics of NIDE at Karachi from August 2014 to January2015. Type 2 diabetic males with self-reported complaints of sexual dysfunction were selectedby non-probability convenient sampling after obtaining well informed consent. Inclusioncriteria was married type 2 diabetic males of age between 35 to 65 years with at least fiveyears duration of type 2 diabetes, taking oral hypoglycemic agents, HbA1c levels between6.5% to 9.4% and living in a stable relation with a female partner for at least one year. Patient’sdemographic, anthropometric, biochemical parameters and sexual history was recorded onpre-designed questionnaire. Arizona Sexual Experience Scale and Diagnostic and StatisticalManual of Mental Disorder-5th edition were used for quantification of sexual dysfunction. Datawas analyzed by SPSS-18, to compute mean ± SD, frequencies and percentages. P-value of<0.05 was taken significant. Results: 95 Patients Type 2 diabetic male patients were recruited;who attended diabetic clinics of NIDE with different types of SD complaints. The mean ageof patients was 53.92 ± 8.17 years with 11.59 ± 3.52 years mean duration of type 2 diabetesmellitus. 81% patients had HbA1c levels of more than 7.4% and overweight patients were52.6%. 77.9% of patients were non-smokers. According to ASEX scale, 100% participantshad clinically significant sexual dysfunction with mean score 17 ± 2.3. 58 patients had singlesexual dysfunction and among them 26.3% had erectile dysfunction, while 36 patients haddouble sexual dysfunctions and among them 20% had combination of erectile dysfunction andpremature ejaculation. Data analysis showed no significant differences in age, duration of type2 diabetes mellitus, HbA1c levels and BMI with participant’s sub-groups having single, doubleand triple sexual dysfunctions. Erectile dysfunction was the most common sexual dysfunctionself-reported by 64.2% patients either as a sole complaint or in combination with other typesof sexual dysfunction, premature ejaculation was reported by 38.9% participants, hypoactivesexual desire disorder was found in 22.1% patients while the least common sexual dysfunctionreported was delayed ejaculation by 14.7% participants. Conclusion: The combination oferectile dysfunction and premature ejaculation is most frequent, followed by the combinationof erectile dysfunction and hypoactive sexual desire disorder. All diabetic men should be askedcarefully about the probable existence of any variety of sexual dysfunctions during their medicalevaluation.

2020 ◽  
Vol 34 (12) ◽  
pp. 107728
Author(s):  
Maurizio De Rocco Ponce ◽  
Andrea Garolla ◽  
Nicola Caretta ◽  
Luca De Toni ◽  
Angelo Avogaro ◽  
...  

2012 ◽  
Vol 59 (7) ◽  
pp. 611-619 ◽  
Author(s):  
Giuseppe Derosa ◽  
Carmine Tinelli ◽  
Angela D^|^rsquo;Angelo ◽  
Gianluca Ferrara ◽  
Aldo Bonaventura ◽  
...  

2018 ◽  
Vol 13 (1) ◽  
pp. 155798831880704
Author(s):  
Moustafa A. Elsaied ◽  
Doaa Masallat ◽  
Ibrahim A. Abdel-Hamid

The aim of this study was to evaluate the levels of adiponectin in diabetic patients with and without erectile dysfunction (ED). In addition, the correlations of adiponectin with the scores of international index of erectile function (IIEF) and total testosterone levels were explored in diabetic and nondiabetic patients with ED. The study included three groups: Type 2 Diabetic patients (T2DM) with and without ED and a third nondiabetics with ED group, each of 29 patients. Fasting blood glucose (FBG), fasting insulin (FI), homeostasis model assessments of insulin resistance (HOMA-IR index), testosterone and adiponectin levels were evaluated. IIEF was applied to diabetic and nondiabetic patients with ED. The results showed that adiponectin was lower in diabetic patients with ED than in both nondiabetics with ED and diabetics without ED groups (5.23 ± 1.05 vs. 11.38 ± 10.08 and 6.5 ± 2.13; p = .003 and .006 respectively). Testosterone was lower in diabetic patients with ED than in diabetics without ED group (2.52 ± 1.15 vs. 4.1 ± 1.46; p = .024). Testosterone had a direct correlation with adiponectin ( r = .371; p = .001). Both adiponectin and testosterone levels did not correlate with IIEF. In conclusion, the decreased adiponectin and testosterone are associated with ED in T2DM. Testosterone has a direct correlation with circulating adiponectin while both have no correlation with IIEF.


Sign in / Sign up

Export Citation Format

Share Document